Exodus Point Capital Management, LP Vanda Pharmaceuticals Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 125,650 shares of VNDA stock, worth $589,298. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125,650Holding current value
$589,298% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
44.7MCall Options Held
167KPut Options Held
33.6K-
Black Rock Inc. New York, NY8.14MShares$38.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.01MShares$18.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$17 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$11 Million0.94% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.26MShares$10.6 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $265M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...